(c) 2024 PillSync.com

skelaxin metaxalone tablet

1 INDICATIONS AND USAGE SKELAXIN is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions in adults and pediatric patients 13 years of age and older. SKELAXIN is a muscle relaxant indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomforts associated with acute, painful musculoskeletal conditions in adults and pediatric patients 13 years of age and older. ( 1 )

pfizer laboratories div pfizer inc

FDA Reported Adverse Reactions
[1] drug ineffective    [2] fatigue    [3] nausea    [4] pain    [5] off label use    [6] headache    [7] diarrhoea    [8] dyspnoea    [9] vomiting    [10] arthralgia   

5 years ago ROUND PINK C 86 62 skelaxin metaxalone tablet

ROUND PINK C 86 62

5 years ago ROUND PINK C 86 62 skelaxin metaxalone tablet

C 86 62 ROUND PINK

16 HOW SUPPLIED/STORAGE AND HANDLING SKELAXIN (metaxalone) tablets are available as 800 mg oval, pink tablets inscribed with 8667 on one side and "S" on the other. Available in bottles of 100 (NDC 60793-136-01) and in bottles of 500 (NDC 60793-136-05). The 400 mg strength of SKELAXIN is not currently marketed by King Pharmaceuticals, Inc. Store at Controlled Room Temperature, between 15°C and 30°C (59°F and 86°F).


More pills like ROUND C 86 62

Related Pills

skelaxin metaxalone tablet

pfizer laboratories div pfizer inc

metaxalone 800 MG Oral Tablet Skelaxin

Pfizer Laboratories Div Pfizer Inc












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site